Tema ETFs’s Cullinan Oncology CGEM Stock Holding History

Tema ETFs’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.03M	Buy	67,125 +4,299	+7%	+$82.3K	0.04%	285
2026 Q2	$1.14M	Buy	62,826 +405	+0.6%	+$6.01K	0.04%	272
2026 Q1	$887K	Buy	62,421 +25,457	+69%	+$327K	0.06%	258
2025 Q4	$383K	Buy	+36,964	New	+$333K	0.03%	413
2025 Q3	–	Sell	-42,692	Closed	-$321K	–	517
2025 Q2	$321K	Buy	42,692 +3,528	+9%	+$28.3K	0.09%	150
2025 Q1	$296K	Buy	39,164 +10,731	+38%	+$103K	0.09%	130
2024 Q4	$346K	Buy	+28,433	New	+$409K	0.14%	122

Other funds holding CGEM

Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Bangor Savings Bank Bangor, Maine $1.31B AUM 12.25% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Tema ETFs's CGEM Position: Q3 2026 in Review

Tema ETFs increased its Cullinan Oncology (CGEM) stake by 6.8% in Q3 2026, buying an estimated $82.3K and bringing the position to 67,125 shares worth $1.03M. The position accounts for 0.04% of the portfolio, ranked #285.

Tema ETFs first reported a position in CGEM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.14M in Q2 2026. 13 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

Tema ETFs held 67,125 shares of Cullinan Oncology worth $1.03M as of Q3 2026.
Tema ETFs bought 4,299 Cullinan Oncology shares in Q3 2026, an estimated $82.3K.
Cullinan Oncology made up 0.04% of Tema ETFs's portfolio in Q3 2026, its #285 holding.
Tema ETFs first reported a position in Cullinan Oncology in Q4 2024 and has held it in 7 quarters since.
Tema ETFs's Cullinan Oncology position peaked at $1.14M in Q2 2026.
13 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.